Insigneo Advisory Services LLC Sells 1,113 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Insigneo Advisory Services LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,777 shares of the healthcare conglomerate’s stock after selling 1,113 shares during the quarter. UnitedHealth Group makes up 0.6% of Insigneo Advisory Services LLC’s holdings, making the stock its 21st largest holding. Insigneo Advisory Services LLC’s holdings in UnitedHealth Group were worth $5,717,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. State Street Corp boosted its position in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares during the period. Bank of New York Mellon Corp grew its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after buying an additional 35,533 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. grew its position in UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after buying an additional 21,149 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $625.26.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $578.97 on Friday. The stock has a market cap of $532.81 billion, a PE ratio of 37.72, a P/E/G ratio of 1.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a fifty day moving average price of $587.48 and a 200 day moving average price of $558.34.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the business posted $6.56 earnings per share. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.